期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (9)
BackgroundA major challenge in stage II colorectal carcinoma is to identify patients with increased risk of recurrence. Biomarkers that distinguish pa......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (9)
Background: Establishing the existence of health inequalities remains a high research and policy agenda item in the United Kingdom. We describe ethnic......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (10)
BackgroundOutcomes for patients with metastatic renal cell carcinoma (mRCC) and tumour thrombus remain poor. Recent data suggest limited role for cyto......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (10)
Background One-third of cancers activate endogenous synthesis of serine/glycine, and can become addicted to this pathway to sustain proliferation and ......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (11)
BackgroundHPV-related cervical cancer (CC) is the fourth most frequent cancer in women worldwide. Cell-free tumour DNA is a potent biomarker to detect......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (11)
Background: Enhancing the response rate of immunotherapy will aid in the success of cancer treatment. Here, we aimed to explore the combined effect of......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (11)
BackgroundPancreatic ductal adenocarcinoma (PDAC) is highly malignant with a very poor prognosis due to its silent development and metastatic profile ......
期刊： BRITISH JOURNAL OF CANCER, 2023; 129 (10)
Background: Oral epithelial dysplasia (OED) is the precursor to oral squamous cell carcinoma which is amongst the top ten cancers worldwide. Prognosti......
期刊： BRITISH JOURNAL OF CANCER, 2023; 129 (10)
BACKGROUND: To investigate the predictive ability of high-throughput MRI with deep survival networks for biochemical recurrence (BCR) of prostate canc......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (6)
BackgroundGRP78 has been implicated in hepatocarcinogenesis. However, the clinical relevance, biological functions and related regulatory mechanisms o......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (9)
In the UK, the National Institute for Health and Care Excellence (NICE) recommends that women at moderate or high risk of breast cancer be offered ris......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (9)
Breast cancer (BC) is the most commonly diagnosed form of cancer and a leading cause of cancer-related deaths among women worldwide. Yes-associated pr......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (12)
BackgroundOnly a subset of gastric cancer (GC) patients with stage II-III benefits from chemotherapy after surgery. Tumour infiltrating lymphocytes pe......
期刊： BRITISH JOURNAL OF CANCER, 2023; 128 (12)
Background: Driver alterations may represent novel candidates for driver gene-guided therapy; however, intrahepatic cholangiocarcinoma (ICC) with mult......
期刊： BRITISH JOURNAL OF CANCER, 2023; 129 (2)
BackgroundStudies to date have yielded inconclusive results as to whether maternal medical history during pregnancy, and a child's early-life medical ......
